August 26, 2026
Advancing Earlier Diagnosis and Coordinated Care in ATTR-CM
For patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), the path to effective care often begins with a challenge: receiving the right diagnosis before the disease irreversibly advances.
Read More ›
May 19, 2026
Scaling with Purpose: Alnylam Publishes 2025 Corporate Responsibility Report
Alnylam's 2025 Corporate Responsibility Report details our progress against our corporate responsibility goals in stories and data.
Read More ›
November 18, 2025
Alnylam Challengers: Empowering Frontline Care for Underserved Communities in Boston
We are investing $2 million to advance the essential work of Boston’s frontline Care Navigators through Alnylam Challengers, our
Read More ›
October 20, 2025
Alnylam’s Commitment to Health Literacy for All
As a patient-centric organization, Alnylam is fully committed to promoting the principles of health literacy as an integral part of our innovation and culture.
Read More ›
May 20, 2025
Alnylam Publishes 2024 Corporate Responsibility Report
We've published our 2024 Corporate Responsibility Report detailing our efforts in our pillars: Patients, Science, Employees, Communities, Planet, and Governance
Read More ›
May 7, 2024
Alnylam Publishes 2023 Corporate Responsibility Report
Alnylam's 2023 Corporate Responsibility Report details our corporate responsibility and ESG efforts and progress.
Read More ›
April 26, 2024
Better Together: Alnylam and Organized Customer Health Systems Want to Improve Access and ...
Alnylam's Head of Strategic Accounts discusses the rise of the Integrated Delivery Network and manufacturer relationship
Read More ›
April 25, 2024
Our Commitment to Patients Means Never Stop Evolving - Our Patient Access Philosophy
Tolga Tanguler, Alnylam's Chief Commercial Officer discusses Alnylam's Patient Access Philosophy and approach to access
Read More ›
May 3, 2023
Building a Corporate Responsibility Program from the Ground Up: Key Learnings from Alnylam ...
If you are building your program or assessing your program, here are five key learnings which may be helpful to your organization
Read More ›
May 9, 2022
Building a Collaborative Framework for Facilitating Patient Access to Innovative Therapies
Alnylam worked with leading European economists and other healthcare experts to develop what we call the Value-Based Negotiation Framework (VBNF) to help...
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site